Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 1/2018

21.04.2017 | Original Article

Correlation of FDG PET/CT Findings with Long-Term Growth and Clinical Course of Abdominal Aortic Aneurysm

verfasst von: Hyunjong Lee, Jin Chul Paeng, Kyung Hwan Kim, Gi Jeong Cheon, Dong Soo Lee, June-Key Chung, Keon Wook Kang

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Herein, we report characteristics of 18F–fluorodeoxyglucose (FDG) uptake in abdominal aortic aneurysms (AAAs) during a long-term follow-up. In addition, we investigated the association between FDG uptake and the physician decision to perform an intervention.

Methods

We performed a retrospective review of 42 patients with AAAs who underwent FDG positron emission tomography (PET)/computed tomography (CT). The size of the AAA was measured in serial CT or PET/CT images. The long-term growth rate of AAAs was calculated by linear regression of the size change. Maximal SUV of the AAA (SUVAAA) and mean SUV of the blood pool (SUVBlood) were measured in PET/CT fusion images. To assess the FDG uptake of AAAs, the target-to-background ratio (TBR) was defined as the ratio of SUVAAA to SUVBlood. We compared FDG uptake of AAAs with the long-term growth rate of AAAs and clinical data.

Results

TBR was not significantly different between patients with and without significant growth (1.55 ± 0.20 vs. 1.57 ± 0.14; P = 0.5599). However, in patients with significant growth, TBR exhibited a significant positive correlation with the growth rate (r 2  = 0.2601, P = 0.0306). TBR also exhibited a significant difference between patients with and without intervention (P = 0.0228).

Conclusion

FDG uptake of AAA is associated with long-term growth of AAAs in a specified group that exhibits growth. FDG PET/CT may only be effective in predicting the long-term growth of AAAs in specific subgroups of patients. It is also suggested that FDG PET is potentially related to the clinical conditions of AAA patients who need surgical or interventional treatment.
Literatur
1.
Zurück zum Zitat Saucy F, Deglise S, Holzer T, Briner L, Benezit M, Delay C, et al. Abdominal aortic aneurysm: what about screening? Curr Pharm Des. 2015;21:4084–7.CrossRefPubMed Saucy F, Deglise S, Holzer T, Briner L, Benezit M, Delay C, et al. Abdominal aortic aneurysm: what about screening? Curr Pharm Des. 2015;21:4084–7.CrossRefPubMed
2.
Zurück zum Zitat Schermerhorn ML, Buck DB, O’Malley AJ, Curran T, McCallum JC, Darling J, et al. Long-term outcomes of abdominal aortic aneurysm in the Medicare population. N Engl J Med. 2015;373:328–38.CrossRefPubMedPubMedCentral Schermerhorn ML, Buck DB, O’Malley AJ, Curran T, McCallum JC, Darling J, et al. Long-term outcomes of abdominal aortic aneurysm in the Medicare population. N Engl J Med. 2015;373:328–38.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Tanios F, Gee M, Pelisek J, Kehl S, Biehler J, Grabher-Meier V, et al. Interaction of biomechanics with extracellular matrix components in abdominal aortic aneurysm wall. Eur J Vasc Endovasc Surg. 2015;50:167–74.CrossRefPubMed Tanios F, Gee M, Pelisek J, Kehl S, Biehler J, Grabher-Meier V, et al. Interaction of biomechanics with extracellular matrix components in abdominal aortic aneurysm wall. Eur J Vasc Endovasc Surg. 2015;50:167–74.CrossRefPubMed
5.
Zurück zum Zitat Larsson E, Labruto F, Gasser TC, Swedenborg J, Hultgren R. Analysis of aortic wall stress and rupture risk in patients with abdominal aortic aneurysm with a gender perspective. J Vasc Surg. 2011;54:295–9.CrossRefPubMed Larsson E, Labruto F, Gasser TC, Swedenborg J, Hultgren R. Analysis of aortic wall stress and rupture risk in patients with abdominal aortic aneurysm with a gender perspective. J Vasc Surg. 2011;54:295–9.CrossRefPubMed
6.
Zurück zum Zitat Reeps C, Gee M, Maier A, Gurdan M, Eckstein H-H, Wall WA. The impact of model assumptions on results of computational mechanics in abdominal aortic aneurysm. J Vasc Surg. 2010;51:679–88.CrossRefPubMed Reeps C, Gee M, Maier A, Gurdan M, Eckstein H-H, Wall WA. The impact of model assumptions on results of computational mechanics in abdominal aortic aneurysm. J Vasc Surg. 2010;51:679–88.CrossRefPubMed
7.
Zurück zum Zitat Nicholls SC, Gardner JB, Meissner MH, Johansen KH. Rupture in small abdominal aortic aneurysms. J Vasc Surg. 1998;28:884–8.CrossRefPubMed Nicholls SC, Gardner JB, Meissner MH, Johansen KH. Rupture in small abdominal aortic aneurysms. J Vasc Surg. 1998;28:884–8.CrossRefPubMed
8.
Zurück zum Zitat Vaidyanathan S, Patel C, Scarsbrook A, Chowdhury F. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70:787–800.CrossRefPubMed Vaidyanathan S, Patel C, Scarsbrook A, Chowdhury F. FDG PET/CT in infection and inflammation—current and emerging clinical applications. Clin Radiol. 2015;70:787–800.CrossRefPubMed
9.
Zurück zum Zitat Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine. 2015;94:e622.CrossRefPubMedPubMedCentral Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine. 2015;94:e622.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39:344–53.CrossRefPubMed Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39:344–53.CrossRefPubMed
11.
Zurück zum Zitat Cocker MS, Mc Ardle B, Spence JD, Lum C, Hammond RR, Ongaro DC, et al. Imaging atherosclerosis with hybrid [18F] fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol. 2012;19:1211–25.CrossRefPubMedPubMedCentral Cocker MS, Mc Ardle B, Spence JD, Lum C, Hammond RR, Ongaro DC, et al. Imaging atherosclerosis with hybrid [18F] fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol. 2012;19:1211–25.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lindeman J, Abdul-Hussien H, Schaapherder A, Roelen D, Kleemann R. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6-and IL-8-dominated inflammatory responses prevail in the human aneurysm. Clin Sci. 2008;114:687–97.CrossRefPubMed Lindeman J, Abdul-Hussien H, Schaapherder A, Roelen D, Kleemann R. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6-and IL-8-dominated inflammatory responses prevail in the human aneurysm. Clin Sci. 2008;114:687–97.CrossRefPubMed
13.
Zurück zum Zitat Sakalihasan N, Van Damme H, Gomez P, Rigo P, Lapiere C, Nusgens B, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2002;23:431–6.CrossRefPubMed Sakalihasan N, Van Damme H, Gomez P, Rigo P, Lapiere C, Nusgens B, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2002;23:431–6.CrossRefPubMed
14.
Zurück zum Zitat Morel O, Mandry D, Micard E, Kauffmann C, Lamiral Z, Verger A, et al. Evidence of cyclic changes in the metabolism of abdominal aortic aneurysms during growth phases: a FDG-PET sequential observational study. J Nucl Med. 2015;56:1030–5.CrossRefPubMed Morel O, Mandry D, Micard E, Kauffmann C, Lamiral Z, Verger A, et al. Evidence of cyclic changes in the metabolism of abdominal aortic aneurysms during growth phases: a FDG-PET sequential observational study. J Nucl Med. 2015;56:1030–5.CrossRefPubMed
15.
Zurück zum Zitat Barwick TD, Lyons O, Mikhaeel N, Waltham M, O’Doherty M. 18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size. Eur J Nucl Med Mol Imaging. 2014;41:2310–8.CrossRefPubMed Barwick TD, Lyons O, Mikhaeel N, Waltham M, O’Doherty M. 18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size. Eur J Nucl Med Mol Imaging. 2014;41:2310–8.CrossRefPubMed
16.
Zurück zum Zitat Choi E-S, Ha S-G, Kim H-S, Ha JH, Paeng JC, Han I. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma. Eur J Nucl Med Mol Imaging. 2013;40:1836–42.CrossRefPubMed Choi E-S, Ha S-G, Kim H-S, Ha JH, Paeng JC, Han I. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma. Eur J Nucl Med Mol Imaging. 2013;40:1836–42.CrossRefPubMed
17.
Zurück zum Zitat Brewstera DC, Cronenwett JL, Hallett JW, Johnston KW, Krupski WC, Matsumura JS. Guidelines for the treatment of abdominal aortic aneurysms: report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg. 2003;37:1106–17.CrossRef Brewstera DC, Cronenwett JL, Hallett JW, Johnston KW, Krupski WC, Matsumura JS. Guidelines for the treatment of abdominal aortic aneurysms: report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg. 2003;37:1106–17.CrossRef
18.
Zurück zum Zitat Lu H-Y, Huang C-Y, Shih C-M, Lin Y-W, Tsai C-S, Lin F-Y, et al. A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms. J Vasc Surg. 2016; doi:10.1016/j.jvs.2016.05.093.PubMedCentral Lu H-Y, Huang C-Y, Shih C-M, Lin Y-W, Tsai C-S, Lin F-Y, et al. A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms. J Vasc Surg. 2016; doi:10.​1016/​j.​jvs.​2016.​05.​093.PubMedCentral
19.
Zurück zum Zitat Vorkapic E, Dugic E, Vikingsson S, Roy J, Mäyränpää MI, Eriksson P, et al. Imatinib treatment attenuates growth and inflammation of angiotensin II induced abdominal aortic aneurysm. Atherosclerosis. 2016;249:101–9.CrossRefPubMed Vorkapic E, Dugic E, Vikingsson S, Roy J, Mäyränpää MI, Eriksson P, et al. Imatinib treatment attenuates growth and inflammation of angiotensin II induced abdominal aortic aneurysm. Atherosclerosis. 2016;249:101–9.CrossRefPubMed
20.
Zurück zum Zitat Lee DH, Lee SJ, Lee D-J, Kwon SH, Jo K-S, An Y-S, et al. Carotid artery FDG uptake may serve as a biomarker for cardiovascular risk stratification in asymptomatic adults. Nucl Med Mol Imaging. 2014;48:196–202.CrossRefPubMedPubMedCentral Lee DH, Lee SJ, Lee D-J, Kwon SH, Jo K-S, An Y-S, et al. Carotid artery FDG uptake may serve as a biomarker for cardiovascular risk stratification in asymptomatic adults. Nucl Med Mol Imaging. 2014;48:196–202.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Özmen Ö, Gökçek A, Tatcı E, Biner İ, Akkalyoncu B. Integration of PET/CT in current diagnostic and response evaluation methods in patients with tuberculosis. Nucl Med Mol Imaging. 2014;48:75–8.CrossRefPubMed Özmen Ö, Gökçek A, Tatcı E, Biner İ, Akkalyoncu B. Integration of PET/CT in current diagnostic and response evaluation methods in patients with tuberculosis. Nucl Med Mol Imaging. 2014;48:75–8.CrossRefPubMed
22.
Zurück zum Zitat Park YH, Yu CM, Kim ES, Jung JO, Seo HS, Lee JH, et al. Monitoring therapeutic response in a case of extrapulmonary tuberculosis by serial F-18 FDG PET/CT. Nucl Med Mol Imaging. 2012;46:69–72.CrossRefPubMed Park YH, Yu CM, Kim ES, Jung JO, Seo HS, Lee JH, et al. Monitoring therapeutic response in a case of extrapulmonary tuberculosis by serial F-18 FDG PET/CT. Nucl Med Mol Imaging. 2012;46:69–72.CrossRefPubMed
23.
Zurück zum Zitat Jalalzadeh H, Indrakusuma R, Planken R, Legemate D, Koelemay M, Balm R. Inflammation as a predictor of abdominal aortic aneurysm growth and rupture: a systematic review of imaging biomarkers. Eur J Vasc Endovasc Surg. 2016;52:333–42.CrossRefPubMed Jalalzadeh H, Indrakusuma R, Planken R, Legemate D, Koelemay M, Balm R. Inflammation as a predictor of abdominal aortic aneurysm growth and rupture: a systematic review of imaging biomarkers. Eur J Vasc Endovasc Surg. 2016;52:333–42.CrossRefPubMed
24.
Zurück zum Zitat Nchimi A, Cheramy-Bien J-P, Gasser TC, Namur G, Gomez P, Seidel L, et al. Multifactorial relationship between 18F-fluoro-deoxy-glucose positron emission tomography signaling and biomechanical properties in unruptured aortic aneurysms. Circ Cardiovasc Imaging. 2014;7:82–91.CrossRefPubMed Nchimi A, Cheramy-Bien J-P, Gasser TC, Namur G, Gomez P, Seidel L, et al. Multifactorial relationship between 18F-fluoro-deoxy-glucose positron emission tomography signaling and biomechanical properties in unruptured aortic aneurysms. Circ Cardiovasc Imaging. 2014;7:82–91.CrossRefPubMed
25.
Zurück zum Zitat Kotze C, Menezes L, Endozo R, Groves A, Ell P, Yusuf S. Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). Eur J Vasc Endovasc Surg. 2009;38:93–9.CrossRefPubMed Kotze C, Menezes L, Endozo R, Groves A, Ell P, Yusuf S. Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). Eur J Vasc Endovasc Surg. 2009;38:93–9.CrossRefPubMed
26.
Zurück zum Zitat Kotze CW, Rudd JH, Ganeshan B, Menezes LJ, Brookes J, Agu O, et al. CT signal heterogeneity of abdominal aortic aneurysm as a possible predictive biomarker for expansion. Atherosclerosis. 2014;233:510–7.CrossRefPubMed Kotze CW, Rudd JH, Ganeshan B, Menezes LJ, Brookes J, Agu O, et al. CT signal heterogeneity of abdominal aortic aneurysm as a possible predictive biomarker for expansion. Atherosclerosis. 2014;233:510–7.CrossRefPubMed
27.
Zurück zum Zitat Satomi T, Ogawa M, Mori I, Ishino S, Kubo K, Magata Y, et al. Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide. J Nucl Med. 2013;54:999–1004.CrossRefPubMed Satomi T, Ogawa M, Mori I, Ishino S, Kubo K, Magata Y, et al. Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide. J Nucl Med. 2013;54:999–1004.CrossRefPubMed
28.
Zurück zum Zitat Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion. Circulation. 2004;110:16–21.CrossRefPubMed Brady AR, Thompson SG, Fowkes FGR, Greenhalgh RM, Powell JT. Abdominal aortic aneurysm expansion. Circulation. 2004;110:16–21.CrossRefPubMed
29.
Zurück zum Zitat Golestani R, Sadeghi MM. Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management. J Nucl Cardiol. 2014;21:251–67.CrossRefPubMedPubMedCentral Golestani R, Sadeghi MM. Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management. J Nucl Cardiol. 2014;21:251–67.CrossRefPubMedPubMedCentral
Metadaten
Titel
Correlation of FDG PET/CT Findings with Long-Term Growth and Clinical Course of Abdominal Aortic Aneurysm
verfasst von
Hyunjong Lee
Jin Chul Paeng
Kyung Hwan Kim
Gi Jeong Cheon
Dong Soo Lee
June-Key Chung
Keon Wook Kang
Publikationsdatum
21.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 1/2018
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-017-0482-9

Weitere Artikel der Ausgabe 1/2018

Nuclear Medicine and Molecular Imaging 1/2018 Zur Ausgabe